P. Grimfjärd

Outcome of percutaneous coronary intervention with the Absorb bioresorbable scaffold: data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).

E. Omerovic, S. James, D. Erlinge, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report

D. Erlinge, B. Svennblad, S. Buccheri, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction

L. Wallentin, E. Omerovic, S. James, 2018, European heart journal. Acute cardiovascular care.

Experience in treatment of metastatic pulmonary carcinoid tumors.

E. Wilander, M. Fjällskog, B. Skogseid, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic

B. Lindahl, E. Omerovic, J. Alfredsson, 2020, Heart.

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction

C. Held, L. Wallentin, E. Omerovic, 2017, The New England journal of medicine.

Clinical use of cangrelor: nationwide experience from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).

D. Erlinge, C. Varenhorst, S. James, 2019, European heart journal. Cardiovascular pharmacotherapy.

Transfection of the multiple endocrine neoplasia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of JunD, delta-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen, and QM/Jif-1.

J. Rastad, B. Skogseid, G. Westin, 2004, The Journal of clinical endocrinology and metabolism.

Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment: A nationwide Swedish registry report.

S. James, D. Erlinge, B. Svennblad, 2016, American heart journal.

Annual report SWEDEHEART 2012

M. Pettersson, I. Karlsson, I. Nyström, 2014 .

Co‐expression of ghrelin and its receptor in pancreatic endocrine tumours

B. Skogseid, M. Stridsberg, L. Grimelius, 2006, Clinical endocrinology.

Prognostic value of early sustained ventricular arrhythmias in ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: A substudy of VALIDATE-SWEDEHEART trial

P. Platonov, S. James, D. Erlinge, 2022, Heart rhythm O2.

Differentially regulated genes in MEN1-transfected BON cells using RT-differential display and oligonucleotide microarrays.

B. Skogseid, P. Stålberg, J. López-Egido, 2009, Anticancer research.